Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025

Reuters

2025/06/03

Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025

Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2540708983"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2540708983\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2540708983?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-03 23:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2540708983","market":"us","top_or_hot":-1,"title":"Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-03 23:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL3RQkZQ:1","article_id":"2540708983","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2540708983","pubTimestamp":1748962835,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025. Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry  Conference. The company unveiled the timsMetabo platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass and ClinDART assay kits with its EVOQ DART-TQ system, aimed at improving therapeutic drug monitoring  and drugs of abuse  analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.Disclaimer: This news brief was created by Public ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","BRKR":"布鲁克","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC"},"translate_title":"布鲁克公司在ASMS 2025上推出用于药物监测和环境分析的质谱学突破性创新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRKR":0.9},"content_text":"Bruker Corporation Unveils Groundbreaking Innovations in Mass Spectrometry for Drug Monitoring and Environmental Analysis at ASMS 2025\n    \n\n        Bruker Corporation has announced significant advancements in mass spectrometry technology at the 73rd American Society for Mass Spectrometry (ASMS) Conference. The company unveiled the timsMetabo™ platform, which offers high-sensitivity analysis for small molecules, specifically targeting PFAS and environmental contaminants. Additionally, Bruker introduced the integration of RECIPE's ClinMass® and ClinDART® assay kits with its EVOQ® DART-TQ⁺ system, aimed at improving therapeutic drug monitoring (TDM) and drugs of abuse (DoA) analysis. These innovations are expected to enhance laboratory productivity by enabling high-throughput, chromatography-free workflows. Bruker plans to further develop solutions for forensic toxicology and emerging contaminants, underlining its commitment to addressing real-world analytical challenges.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250603080303) on June 03, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}